Picture

AstraZeneca - ADDC Collaboration

The collaboration allows for ADDC members to have direct access to the AstraZeneca's library of compounds.

This collaboration between ADDC and AstraZeneca is aimed at at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application.
Click here for more information

Highlighted Partnerships

CDRD

 Share resources for the discovery of new drugs stemming rom CDRD and IPS.

Creative BioMart


Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecu...

CEO

development of peptide therapeutics to metastatic cancer

The Division of Signal Transduction Therapy

A vital asset of the MRC-PPU is the Division of Signal Transduction Therapy (DSTT) which was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU (all PIs...

Argenta and ANTABIO Announce Drug Discovery Collaboration

Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration pa...

Number of Registered Partnerships

47

So Far
Therapeuitic Areas of Expertise
  • Choices
    Percentage
  • Oncology
     
    29.79%
  • Infectious Diseases
     
    12.77%
  • Neurological Disorders
     
    31.91%
  • Immunology
     
    23.4%
  • Metabolic Disorders
     
    21.28%
  • Cardiology
     
    12.77%
  • Pain
     
    6.38%
  • Other
     
    12.77%
  •  
Therapeutic Approaches
  • Choices
    Percentage
  • Small Molecules
     
    76.6%
  • Biologics
     
    38.3%
  • Biomarkers
     
    2.13%
  • Drug Delivery
     
    2.13%
  • Stem Cells
     
    2.13%
  • Vaccines
     
    0%
  • Antibodies
     
    8.51%
  • Other
     
    2.13%
  •